BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Lunit Partners with Microsoft to Scale AI-Powered Cancer Diagnostics Globally

Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, announced a collaboration with Microsoft to accelerate the deliver...

July 03, 2025 | News

Seegene Launches STAgora™ to Deliver Real-Time Infectious Disease Intelligence and Predictive Insights

Real-time analytics that empower clinical decision-making and pandemic preparedness Global unveiling at ADLM 2025 in Chicago to initiate business p...

July 02, 2025 | News

LUCA AICELL Launches Drug-Free Nasal Spray to Shield Against COVID-19, Influenza, and Mycoplasma Pneumonia

As respiratory illnesses like COVID-19, influenza, and Mycoplasma pneumonia continue to spread, the need for safe, non-pharmaceutical prevention optio...

June 30, 2025 | News

Quanterix Expands Global Reach with South Korea Approval for HD-X Simoa Immunoassay Analyzer

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that the HD-X ...

June 26, 2025 | News

Novogene Establishes Korean Subsidiary to Strengthen Multi-Omics Innovation and Local Collaboration

Novogene, a global leader in next-generation sequencing (NGS) and multi-omics solutions, today announced the establishment ofNovogene Korea ...

June 23, 2025 | News

SHP Forges Strategic South Korea Ties to Drive AI-Led Innovation in Primary Care

The 10th Asia Pacific Primary Care Research Conference (APPCRC) 2025 commenced at the Academia, SGH Campus, was jointly hosted by SingHealth Po...

June 19, 2025 | News

LOTTE BIOLOGICS Expands Global CDMO Footprint with Antibody Therapeutics Deal with Ottimo Pharma

Expanding track record by signing contracts with various global companies across Asia and Europe LOTTE BIOLOGICS announced on June 19, 2025 that it ha...

June 19, 2025 | News

Cytiva’s $1.6B Expansion Across 3 Continents to Boost Bioprocessing Supply

Faster delivery and productivity gains available thanks to expanded manufacturing capacity in chromatography resins, filtration, single-use bags and ...

June 12, 2025 | News

Sweden’s Salipro Biotech Partners with South Korea’s Daewoong Pharmaceutical to Target Challenging Drug Discovery

- The collaboration combines Salipro Biotech's unique expertise and its Salipro® platform technology to stabilize a challenging drug target and advance...

June 12, 2025 | News

Samsung Bioepis Partners with NIPRO to Expand Biosimilar Access in Japan

Samsung Bioepis expands its presence in Japanese market through partnership with NIPRO Corporation Marks a step forward in widening treatments options a...

June 09, 2025 | News

CorestemChemon's Neuronata-R® Shows Promising Efficacy in Early-Stage ALS, Sets Sights on Accelerated FDA Approval

Neuronata-R®, an autologous bone marrow-derived mesenchymal stem cell (MSC) therapy for amyotrophic lateral sclerosis (ALS), has demonstrated meaningfu...

May 30, 2025 | News

Huonslab Completes Patient Enrollment for Pivotal Phase 1 Trial of HLB3-002 in South Korea

Phase 1 Pivotal Study in Korea for HLB3-002 Plans to apply for marketing approval with the MFDS by the 2H 2025 -Huonslab Co., Ltd. (&ldq...

May 27, 2025 | News

Celltrion’s YUFLYMA® Wins Expanded Interchangeability Status for All Humira® Dosage Forms in the U.S.

YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar[1] Cellt...

May 26, 2025 | News

Celltrion’s YUFLYMA® Granted Full FDA Interchangeability with Humira® Across All Dosage Forms

YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar[1] Cellt...

May 22, 2025 | News

Stay Connected